Table 1 Patients characteristics separated by tertiles of the percentage of ECW BIA to TBW Watson
Population characteristics | Percentage of ECWBIAto TBWWatson | P for ANOVA | ||
|---|---|---|---|---|
|  | Tertile 1 (n = 50) (27 men with <38.3% and 23 women with <37.0%) | Tertile 2 (n = 49) (26 men with 38.3%–41.0% and 23 women with 37.0%–39.4%) | Tertile 3 (n = 50) (27 men with ≥41.1% and 23 women with ≥39.5%) | |
Age, years | 62.0 ± 16.6 | 61.8 ± 15.1 | 67.1 ± 16.4 | 0.18 |
Height, cm | 159 ± 10 | 159 ± 11 | 161 ± 8 | 0.46 |
Weight, kg | 61 ± 15 | 56 ± 12 | 56 ± 10 | 0.09 |
Body surface area, m2 | 1.62 ± 0.21 | 1.56 ± 0.21 | 1.58 ± 0.16 | 0.41 |
Body mass index, kg/m2 | 24.0 ± 4.2 | 22.0 ± 3.5 | 21.6 ± 2.9 | <0.01 |
Underlying disease | Â | Â | Â | Â |
Glomerulonephritis, n (%) | 23 (46.0) | 22 (45.0) | 17 (34.0) | 0.41 |
Diabetes mellitus, n (%) | 4 (8.0) | 7 (14.3) | 13 (26.0) | <0.05 |
Nephrosclerosis, n (%) | 9 (18.0) | 10 (20.4) | 9 (18.0) | 0.94 |
ADPKD, n (%) | 0 (0.0) | 0 (0.0) | 1 (2.0) | 0.37 |
Others, n (%) | 14 (28.0) | 10 (20.4) | 10 (20.0) | 0.56 |
Systolic blood pressure, mmHg | 127 ± 19 | 122 ± 17 | 129 ± 21 | 0.19 |
Diastolic blood pressure, mmHg | 75 ± 11 | 71 ± 9 | 69 ± 10 | <0.01 |
Pulse pressure, mmHg | 52 ± 11 | 51 ± 13 | 60 ± 17 | <0.01 |
Resistant high blood pressure, n (%) | 6 (12.0) | 12 (24.5) | 19 (38.0) | <0.05 |
TBWBIA, L (% in BW) | 30.1 ± 7.5 | 30.9 ± 7.2 | 32.7 ± 5.6 | 0.14 |
(49.6 ± 5.6) | (55.3 ± 5.6) | (58.7 ± 5.1) | (<0.001) | |
ICWBIA, L (% in BW) | 18.4 ± 4.7 | 18.8 ± 4.6 | 19.7 ± 3.4 | 0.30 |
(30.2 ± 3.5) | (33.5 ± 3.8) | (35.2 ± 3.2) | (<0.001) | |
ECWBIA, L (% in BW) | 11.7 ± 2.8 | 12.1 ± 2.6 | 13.1 ± 2.2 | 0.02 |
(19.3 ± 2.1) | (21.7 ± 2.0) | (23.4 ± 2.1) | (<0.001) | |
Serum creatinine, mg/dL | 1.67 ± 1.17 | 1.76 ± 1.27 | 2.55 ± 1.78 | <0.01 |
eGFRCKD-EPI, ml/min per 1.73 m2 | 71.7 ± 48.8 | 71.0 ± 52.7 | 48.9 ± 46.2 | <0.05 |
Serum albumin, g/dL | 4.1 ± 0.4 | 4.0 ± 0.4 | 3.7 ± 0.5 | <0.001 |
Total cholesterol, mg/dL | 200 ± 34 | 193 ± 36 | 191 ± 55 | 0.53 |
Triglycerides, mg/dL | 147 ± 71 | 139 ± 95 | 129 ± 88 | 0.55 |
Fasting blood glucose, mg/dL | 103 ± 19 | 132 ± 45 | 134 ± 42 | <0.05 |
UPCR, g/g · Cr | 0.9 ± 1.5 | 0.8 ± 1.3 | 1.6 ± 1.9 | <0.05 |
Uric acid, >7.0Â mg/dL in men or >6.0Â mg/dL in women, n (%) | 23 (46.9) | 27 (55.1) | 32 (64.0) | 0.23 |
24-hour urinary urea nitrogen excretion, g/day | 2.1 ± 1.0 | 2.5 ± 1.9 | 2.2 ± 1.5 | 0.40 |
24-hour urinary creatinine excretion, g/day | 1.5 ± 1.1 | 1.6 ± 1.5 | 1.5 ± 0.8 | 0.81 |
24-hour urinary sodium excretion, mmol/day | 143 ± 58 | 128 ± 50 | 130 ± 54 | 0.37 |
Furosemide, n (%) | 5 (10.0) | 6 (12.2) | 18 (36.0) | <0.01 |
Other diuretics, n (%) | 7 (14.0) | 7 (14.3) | 6 (12.0) | 0.94 |
ACE inhibitors, n (%) | 14 (28.0) | 17 (34.7) | 16 (32.0) | 0.77 |
AT1-R blockers, n (%) | 30 (60.0) | 28 (57.1) | 25 (50.0) | 0.58 |
Other antihypertensives | 20 (40.0) | 25 (51.0) | 31 (62.0) | 0.09 |